Treatment of granuloma annulare and suppression of proinflammatory cytokine activity with tofacitinib

Piette, 2016, Granuloma annulare: clinical and histologic variants, epidemiology, and genetics, J Am Acad Dermatol, 75, 457, 10.1016/j.jaad.2015.03.054 Schmieder, 2020, Granuloma annulare Rubin, 2019, Granuloma annulare: a retrospective series of 133 patients, Cutis, 103, 102 Piette, 2016, Granuloma annulare: pathogenesis, disease associations and triggers, and therapeutic options, J Am Acad Dermatol, 75, 467, 10.1016/j.jaad.2015.03.055 Thornsberry, 2013, Etiology, diagnosis, and therapeutic management of granuloma annulare: an update, Am J Clin Dermatol, 14, 279, 10.1007/s40257-013-0029-5 Exarchou, 2009, Immune-mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitors, Scand J Rheumatol, 38, 328, 10.1080/03009740902922612 Grewal, 2017, Antimalarial therapy for granuloma annulare: results of a retrospective analysis, J Am Acad Dermatol, 76, 765, 10.1016/j.jaad.2016.11.044 Stefanaki, 2007, Histological and immunohistochemical study of granuloma annulare and subcutaneous granuloma annulare in children, J Cutan Pathol, 34, 392, 10.1111/j.1600-0560.2006.00626.x Mempel, 2002, T-cell receptor repertoire and cytokine pattern in granuloma annulare: defining a particular type of cutaneous granulomatous inflammation, J Invest Dermatol, 118, 957, 10.1046/j.1523-1747.2002.01783.x Cornejo, 2019, Immune checkpoint inhibitors and the development of granulomatous reactions, J Am Acad Dermatol, 81, 1165, 10.1016/j.jaad.2018.07.051 Friedman-Birnbaum, 1978, Histocompatibility antigens in granuloma annulare: comparative study of the generalized and localized types, Br J Dermatol, 98, 425, 10.1111/j.1365-2133.1978.tb06536.x Min, 2020, Granuloma annulare skin profile shows activation of T-helper cell type 1, T-helper cell type 2, and Janus kinase pathways, J Am Acad Dermatol, 83, 63, 10.1016/j.jaad.2019.12.028 Finlay, 1995, The effect of severe psoriasis on the quality of life of 369 patients, Br J Dermatol, 132, 236, 10.1111/j.1365-2133.1995.tb05019.x Gelfand, 2006, Risk of myocardial infarction in patients with psoriasis, JAMA, 296, 1735, 10.1001/jama.296.14.1735 Prodanovich, 2005, Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis, J Am Acad Dermatol, 52, 262, 10.1016/j.jaad.2004.06.017 Ahlehoff, 2013, Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study, J Intern Med, 273, 197, 10.1111/j.1365-2796.2012.02593.x Wu, 2017, Cardiovascular event risk assessment in psoriasis patients treated with tumor necrosis factor-alpha inhibitors versus methotrexate, J Am Acad Dermatol, 76, 81, 10.1016/j.jaad.2016.07.042 Matos, 2017, Clinically resolved psoriatic lesions contain psoriasis-specific IL-17-producing alphabeta T cell clones, J Clin Invest, 127, 4031, 10.1172/JCI93396 Kerdiles, 2009, Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor, Nat Immunol, 10, 176, 10.1038/ni.1689 Leonard, 2016, IL-21 signaling in immunity, F1000Res, 5, 1, 10.12688/f1000research.7634.1 Curtsinger, 2012, Autocrine IFN-gamma promotes naive CD8 T cell differentiation and synergizes with IFN-alpha to stimulate strong function, J Immunol, 189, 659, 10.4049/jimmunol.1102727 Murray, 2017, Macrophage polarization, Annu Rev Physiol, 79, 541, 10.1146/annurev-physiol-022516-034339 Kaufmann, 2001, Increase of CCR1 and CCR5 expression and enhanced functional response to MIP-1 alpha during differentiation of human monocytes to macrophages, J Leukoc Biol, 69, 248, 10.1189/jlb.69.2.248 Denhardt, 2001, Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival, J Clin Invest, 107, 1055, 10.1172/JCI12980 Nakamura, 2004, Hepatocyte proliferation and tissue remodeling is impaired after liver injury in oncostatin M receptor knockout mice, Hepatology, 39, 635, 10.1002/hep.20086 Grinnell, 1984, Fibronectin and wound healing, J Cell Biochem, 26, 107, 10.1002/jcb.240260206 Gonzalez-Gonzalez, 2018, Alonso J. Periostin: a matricellular protein with multiple functions in cancer development and progression, Front Oncol, 8, 225, 10.3389/fonc.2018.00225 Conway, 2014, The role of periostin in tissue remodeling across health and disease, Cell Mol Life Sci, 71, 1279, 10.1007/s00018-013-1494-y Rautela, 2017, IL-15 signaling in NK cell cancer immunotherapy, Curr Opin Immunol, 44, 1, 10.1016/j.coi.2016.10.004 Damsky, 2020, Janus kinase inhibition induces disease remission in cutaneous sarcoidosis and granuloma annulare, J Am Acad Dermatol, 82, 612, 10.1016/j.jaad.2019.05.098 Wiig, 2010, Interstitial fluid: the overlooked component of the tumor microenvironment?, Fibrogenesis Tissue Repair, 3, 12, 10.1186/1755-1536-3-12 Richards, 2019, Oncostatin M in the regulation of connective tissue cells and macrophages in pulmonary disease, Biomedicines, 7, 1, 10.3390/biomedicines7040095 Gjerde, 2016, Medication reconciliation of patients with hip fracture by clinical pharmacists, Eur J Hosp Pharm, 23, 166, 10.1136/ejhpharm-2015-000741 Su, 2015, Osteopontin promotes oncostatin M production in human osteoblasts: implication of rheumatoid arthritis therapy, J Immunol, 195, 3355, 10.4049/jimmunol.1403191 Zollinger, 2017, Fibronectin, the extracellular glue, Matrix Biol, 60-61, 27, 10.1016/j.matbio.2016.07.011 Oikarinen, 1989, Biochemical and immunohistochemical comparison of collagen in granuloma annulare and skin sarcoidosis, Acta Derm Venereol, 69, 277 Koh, 1984, Increased plasma fibronectin in diabetes mellitus, necrobiosis lipoidica and widespread granuloma annulare, Clin Exp Dermatol, 9, 293, 10.1111/j.1365-2230.1984.tb00800.x Wahlstrom, 2009, Autoimmune T cell responses to antigenic peptides presented by bronchoalveolar lavage cell HLA-DR molecules in sarcoidosis, Clin Immunol, 133, 353, 10.1016/j.clim.2009.08.008 Grunewald, 2016, T-cell receptor-HLA-DRB1 associations suggest specific antigens in pulmonary sarcoidosis, Eur Respir J, 47, 898, 10.1183/13993003.01209-2015 Damsky, 2020, Treatment of granuloma annulare with tofacitinib 2% ointment, JAAD Case Rep, 6, 69, 10.1016/j.jdcr.2019.10.016